HROW - Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA -Approved Nasal Spray for Dry Eye Disease
HROW - Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA -Approved Nasal Spray for Dry Eye Disease
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.